Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.8.0.1
Consolidated Statements of Cash Flows
$ in Thousands
12 Months Ended
Dec. 30, 2017
USD ($)
Dec. 31, 2016
USD ($)
Jan. 02, 2016
USD ($)
Operating activities      
Net income (loss) $ 24,015 $ (603) $ (2,424)
Adjustments to reconcile net loss to net cash (used in) provided by operating activities:      
Depreciation and amortization expense 6,397 7,510 7,510
Amortization of intangible assets 319 482 464
Deferred income taxes (21,476) (838) (906)
Share-based compensation expense 2,842 3,131 2,419
Stock awards issued for non-employee director service 9 9 2
Impairment loss on intangible assets 0 1,130 0
Amortization of deferred financing costs 32 70 82
Gain from disposition of assets (8) 0 (13)
Changes in operating assets and liabilities:      
Accounts receivable 796 (30) 568
Inventory (3,327) 312 (2,854)
Other current assets (292) (255) 262
Other non-current assets 40 203 225
Accounts payable and accrued expenses 2,725 7,906 119
Other current liabilities (712) 1,775 475
Other non-current liabilities 274 769 (184)
Net cash provided by operating activities 11,634 21,571 5,745
Investing activities      
Additions to property and equipment (4,896) (6,353) (7,780)
Proceeds from sale of property and equipment 39 0 13
Cash paid for intangibles 0 (125) (25)
Proceeds from sale of marketable securities and investments 0 1 0
Net cash used in investing activities (4,857) (6,477) (7,792)
Financing activities      
Proceeds from revolving loan payable 3,835 13,727 15,637
Payments made on revolving loan payable (3,835) (25,485) (14,900)
Minority shareholder redemption (2,486) 0 0
Payments on capital leases (561) (587) (438)
Treasury stock purchases (5,823) (1,387) 0
Statutory tax withholding payment for share-based compensation (1,644) (969) (438)
Proceeds from exercise of stock options 258 908 134
Payment of liabilities related to financing activities (100) (100) (100)
Preferred stock dividends paid (209) (61) 0
Net cash (used in) provided by financing activities (10,565) (13,954) (105)
Effect of exchange rate changes on cash (5) (34) 36
Net change in cash and cash equivalents (3,793) 1,106 (2,116)
Cash and cash equivalents, beginning of period 6,643 5,537 7,653
Cash and cash equivalents, end of period 2,850 6,643 5,537
Supplemental disclosure of non-cash investing and financing activities:      
Accrued asset purchases 831 744 708
Accrued intangible asset purchases 0 0 125
Property acquired under capital lease 0 211 1,588
Preferred stock dividends declared and not paid 0 60 0
Unrealized loss on investments 0 (2) 0
Supplemental disclosure of cash flow information:      
Cash paid during the period for income taxes 78 89 104
Cash paid during the period for interest $ 1,536 $ 1,077 $ 1,145